Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
RESEARCH TOOLSreports
Holding MIRA?
Track your performance easily
MIRA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.51 - $5.01
Previous Close$1.27
Volume458.43K
Average Volume (3M)2.03M
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$4.14M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-2.58
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding16,560,852
10 Day Avg. Volume575,324
30 Day Avg. Volume2,034,165
Standard Deviation0.76
R-Squared0.02
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)5.75
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$17.00Price Target Upside1249.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
MIRA Pharmaceuticals, Inc. News
PremiumCompany Announcements
MIRA Pharmaceuticals Appoints New Board Member and Chairman
Ownership Overview
21.69% Insiders
0.06% Mutual Funds
3.17% Other Institutional Investors
75.08% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MIRA FAQ
What was MIRA Pharmaceuticals, Inc.’s price range in the past 12 months?
MIRA Pharmaceuticals, Inc. lowest stock price was $0.51 and its highest was $5.01 in the past 12 months.
What is MIRA Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is MIRA Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MIRA Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is MIRA Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts MIRA Pharmaceuticals, Inc.’s price is currently Undervalued.
Does MIRA Pharmaceuticals, Inc. pay dividends?
MIRA Pharmaceuticals, Inc. does not currently pay dividends.
What is MIRA Pharmaceuticals, Inc.’s EPS estimate?
MIRA Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MIRA Pharmaceuticals, Inc. have?
MIRA Pharmaceuticals, Inc. has 16,560,852 shares outstanding.
What happened to MIRA Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MIRA Pharmaceuticals, Inc.?
Among the largest hedge funds holding MIRA Pharmaceuticals, Inc.’s share is Suncoast Equity Management. It holds MIRA Pharmaceuticals, Inc.’s shares valued at 117K.
---
MIRA Pharmaceuticals, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.00 (1249.21% Upside)
$17.00 (1249.21% Upside)
Hedge Fund Trend
Increased
By 50.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $392.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 33.1%
Last 30 Days ▲ 33.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-72.79%
12-Months-Change
Fundamentals
Return on Equity
-192.32%
Trailing 12-Months
Asset Growth
-52.69%
Trailing 12-Months
Company Description
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
---
MIRA Stock 12 Month Forecast
Average Price Target
$17.00
▲(1249.21% Upside)
Technical Analysis
Best Analysts Covering MIRA
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-2.60%
initiated a buy rating 2 months ago
Copying Elemer Piros's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -2.60% per trade.
---